Zenas BioPharma, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin -73.65%-3,218.36%
EBIT Margin -74.29%-3,277.76%
EBITDA Margin -74.09%-3,136.62%
Operating Margin -74.29%-3,277.76%
Net Margin -74.25%-3,226.94%
FCF Margin -61.09%-2,396.10%
Efficiency
Assets Average 219.07M
Equity Average 43.37M
Invested Capital -225.72M312.46M
Asset Utilization Ratio 0.02
Leverage & Solvency
Equity Ratio -3.310.84
Valuation
Enterprise Value -56.86M-8.50M
Market Capitalization 342.27M
Return Ratios
Return on Sales -0.74%-32.27%
Return on Capital Employed -1.01%
Return on Assets -0.74%
Return on Equity -3.72%